Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
about
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesisMatricellular proteins: a sticky affair with cancersExtracellular matrix associated protein CYR61 is linked to prostate cancer developmentThe role of integrins in TGFβ activation in the tumour stromaTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsAnalysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells.CCN1/CYR61: the very model of a modern matricellular protein.Inhibiting CCN1 blocks AML cell growth by disrupting the MEK/ERK pathway.Cell-to-cell signaling influences the fate of prostate cancer stem cells and their potential to generate more aggressive tumors.Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.Cyr61 expression is associated with prognosis in patients with colorectal cancer.Decreased expression of Cyr61 is associated with prostate cancer recurrence after surgical treatment.Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma.Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationCyr61, a matricellular protein, is needed for dendritic arborization of hippocampal neurons.Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.The prometastatic ribosomal S6 kinase 2-cAMP response element-binding protein (RSK2-CREB) signaling pathway up-regulates the actin-binding protein fascin-1 to promote tumor metastasisThe CCN family proteins: modulators of bone development and novel targets in bone-associated tumorsThe matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.Cyr61 is a potential prognostic marker for prostate cancer.Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium.Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells.Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.Differential Effects of MicroRNAs on Glioblastoma Growth and Migration.CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer.The matrix protein CCN1/CYR61 is required for α(V)β5-mediated cancer cell migration.Stathmin 1 is a potential novel oncogene in melanoma.Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness.MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop.EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor.FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes.A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.Differential regulation of the androgen receptor by protein phosphatase regulatory subunits.A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk.Knockdown of cysteine-rich 61 inhibits proliferation, migration, and invasiveness of prostate carcinoma PC-3 cells
P2860
Q21245763-2BB7B2C1-B731-4710-BE50-FCB828D84BC9Q21296660-45731BB7-2C00-4433-AB8C-A85781A927C9Q24623715-77C3F4F0-8B27-4253-B9B7-0D9808A8B81FQ28068373-AB055BA2-1930-4F26-BB02-A7DD5A95F504Q28254386-52415ADA-F574-4FFE-85F9-698C18EBB51BQ33867402-A4A50B10-45C7-410A-A788-632161F0E86AQ34027926-636A8C48-5783-49D2-8AE7-99D56D7FAF4DQ34127147-A2919EB9-2C61-4D8E-A3FF-B139389E1EA4Q34157307-B333F868-2CFC-4C87-BE56-A382CF33CA9CQ34250119-6D265147-AC4F-48F5-B3AA-C0FFE83C827BQ34946548-E2AA45E0-262D-4FF5-BBB3-9A325B29C577Q35113999-5CD9290F-073F-4594-8551-2334CDA8A2D9Q35176786-91781C6B-1891-498D-A30F-E17652F65259Q35236809-012101E7-C839-4212-A9E9-FACE35EA6162Q35748636-E8665DFA-2A09-4C20-B1F4-70F2B9CEA262Q36004674-79FF78E6-BB3B-4644-8EBC-EC5DB25B136CQ36151613-3FB9073A-76BE-4096-9275-DCA30354000BQ36578825-25A21876-D78C-4DC8-9746-B666C3C1F71EQ36708627-EBCA2171-30D2-42B2-9B23-EFEA1A11F1BDQ37097562-A123B3C3-9E0F-4E20-94EC-2B7A66F5227DQ37289259-94A4C57B-85FB-4F37-992E-8EB14E10FCF6Q37557267-1704B302-757C-45B8-B0F0-AD0BAEE33AA1Q37705939-E18DDE3D-848F-4D7E-B186-57C225DCC773Q37985500-F476875F-E453-4C4F-BEAF-0F79982C5A14Q38697619-63453908-1B83-436D-AD9B-99017A1EF689Q38899609-293C2B71-6BC3-491B-9F21-1EB864416EF6Q38975050-8392027E-083D-4945-B9DD-93E63DB6C010Q39219681-091FF84B-A511-4C17-A660-92DA8A5335BAQ39321392-47357DAE-989F-45DE-A633-391A766C7AA3Q39332268-5C5CE339-70F0-4E97-869A-29C070B65946Q39337144-4D62AC8E-D4C7-4B50-BE76-A1E9A9CDCAF5Q39453245-676226D3-EA0F-42B5-B63A-B3F516D15A6DQ39523091-3DE2ECA8-6BD4-4EBF-BE92-5187EFA7FB75Q42531627-0640CE65-AD61-41EE-8A59-A260CE0925DEQ46095419-BA86D92D-39B5-4403-BAFF-8754393C51B9Q47547132-0B7CDDF7-45C5-4D47-B1E2-602967C397B4Q48183094-D352BF3C-CAE9-4ACA-92B8-ABB5F2D9FA52Q49881707-020C3333-19AD-49BA-A0BA-909F1A5FB527Q54288719-E23B69F7-1700-4164-ACC5-C41222FD708AQ58139757-D6577011-23CA-4963-8BD9-986DF5651C83
P2860
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@ast
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@en
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@nl
type
label
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@ast
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@en
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@nl
prefLabel
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@ast
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@en
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@nl
P2093
P2860
P3181
P356
P1476
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6604712
P407
P577
2008-11-18T00:00:00Z
P5875
P6179
1000567383